FREQUENCY OF URINARY TRACT INFECTION (UTI) IN PATIENTS UNDERWENT TRANSURETHRAL RESECTION OF PROSTATE (TURP) AND CHARACTERIZATION OF CAUSATIVE AGENT
DOI:
https://doi.org/10.69723/njms.04.02.0564Keywords:
urinary tract infection, causative agent, transurethral resection of prostateAbstract
OBJECTIVE: To determine the frequency of urinary tract infection and identification of causative agent after transurethral resection of prostate in patients at Institute of Kidney Diseases, Peshawar.
METHODOLOGY: This study was conducted at Department of Urology, Institute of Kidney Diseases, Hayatabad, Peshawar from the period of six months (29/1/2024 to 29/6/2024). Study design was cross sectional in which a total of 103 patients were observed. All the patients undergoing transurethral resection of prostate, with negative urine culture, in age between 45 to 70 years were included. A detailed history, physical examination; investigations including Urine R/E & Urine Culture and Ultrasound Kidney Ureter Bladder were performed and the selected patients were subjected to Operation Theatre for transurethral resection of prostate. Followed up after 24 hours, 3rd and 7th post operative day for the . Data was then entered and analyzed in statistical software (SPSS) version 23.0.
RESULTS: In this study 103 patients were observed; mean age was 60.30 years ± 6.776. The frequency of Urinary Tract Infection was 19(18%) in which 13(69%) patients had Eschericia coli, 3(16%) patients had Enterococcus, 2(12%) patients had Klebsiella, 1(3%) patient had Proteus.
References
Stangl-Kremser J, Brönimann S, Abufaraj M, Pozo C, Shariat SF, et al. Risk factors for urinary tract infection in men treated with transurethral resection of the prostate for lower urinary tract symptoms. Int Arch Urol Complic. 2019;5:62-7. doi:10.23937/2469-5742/1510062.
Miernik A, Gratzke C. Current treatment for benign prostatic hyperplasia. Dtsch Arztebl Int. 2020;117(49):843-7. DOI: 10.3238/arztebl.2020.0843
Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections. Int J Health Sci 2019;13 (2):48-55
Teo JS, Lee YM, Ho HSS. An update on transurethral surgery for benign prostatic obstruction. Asian J Urol. 2017;4(3):195-8. DOI: 10.1016/j.ajur.2017.06.006
Diagana M, Tfeil Y, Boya MM, Essalem MB. Transurethral Resection of the Prostate (TURP): about 146 Cases at Sheikh Zayed Hospital in Nouakchott Mauritania. Open J Urology. 2021;11(12):518-24. DOI: 10.4236/oju.2021.1112052
Al-Fatlawi BG, Jasim AL. Determining the prevalence of upper and lower urinary tract infections’ pathogens and their antibiotic susceptibility profile for adult patients in Al-Diwaniya, Iraq. Iraqi J Pharm Sci. 2022;31(1):86-91.
Akpayak IC, Shuaibu SI, Onowa VE, Agbo CA. Early VS delayed foley catheter removal after transurethral resection of the prostate. Nigerian J Med 2020;29:111-4.
Welliver C, Feinstein L, Ward JB, Fwu CW, Kirkali Z, Bavendam T, et al. Urologic diseases in America project. Trends in lower urinary tract symptoms associated with benign prostatic hyperplasia, 2004 to 2013:the urologic diseases in America project. J Urol. 2020;203(1):171-8. Doi:10.1097/ju.0000000000000499
Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J Urol. 2021;206(4):818-26. DOI: 10.1097/JU.0000000000002183
Khawcharoenporn T, Kanoktipakorn P, Thammasat, Thep K. Effectiveness of antibiotic prophylaxis among patients undergoing elective transurethral resection of the prostate in the era of antibiotic resistance. Open Forum Infec Dis.2020;7(1):S179. DOI: 10.1017/ice.2021.299
Kohada Y, Goriki A, Yukihiro K, Ohara S, Kajiwara M. The risk factors of urinary tract infection after transurethral resection of bladder tumors. World J Urol. 2019;37(12):2715-9. DOI: 10.1007/s00345-019-02737-3
LI YH, LI GQ, Guo sm, Che YN, Wang X, Cheng FT. Clinical analysis of urinary tract infection in patients undergoing transurethral resection of the prostate. Eur Rev Med Phar Sci. 2017;21:4487-92.
Colau A., Lucet J.C., Rufat P., Botto H., Benoit G., Jardin A. Incidence and risk factors of bacteriuria after transurethral resection of the prostate. Eur Urol. 2001;39:272–6. DOI: 10.1159/000052452
Amu OC, Affusim EA, Mbadiwe O, Nwachukwu DO, Anyimba SK. Postoperative incidence of symptomatic urinary tract infection (uti) and microbial pattern seenin TURP patients with negative cultures preoperatively. Eur J Med Health Sci. 2024;6(1):84-7.
Kusnawan A, Pramod SV, Safriadi F. Urinary tract infection in patients after transurethral resection of bladder tumor procedure at a tertiary hospital. Asian Pac J Cancer Care.2023;8(4):669-73. DOI 10.31557/apjcc.2023.8.4.669-673
Lin J, Yang Z, Ye L, Hong Y, Cai W, Pan H, et l. Pathogen species are the risk factors for postoperative infection of patients with transurethral resection of the prostate: a retrospective study. Scientific Reports. 2023;13:20943-9. Doi : 10.1038/s41598-023-47773-7
Martínez-Delgado GH, Garza-Gangemi AM, Castillejos Molina RA. Urinary tract infections after transurethral resection of the bladder: Microbiology, antibiotic resistance, and associated risk factors. Revista Mexicana de Urología. 2020;80(4):1-12
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Afnan, MOHAMMAD ASAD SHAMSHER, MUHAMMAD SAAD HAMID, IMMAD AHMED, khizer zaman, NAUMAN UL MULK
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
